ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #2,393Top JournalHybrid

Harm Reduction Journal

Identifier (ISSN):1477-7517(Print)
•
Publisher:Springer Nature
Clarivate JCR Index Advisory: Active (SSCI)
Clarivate IF (2026)
4.2↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2022–2026)

Clarivate IF trend for Harm Reduction Journal

WoS Q1
24574.7620224.4202342024420254.22026
Annual Impact Factor Metric
Current (2026):4.2
Scopus SJR & RankScopus Q1
1.513
#2,393

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
76

76 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate12.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
126articles/year
99.83% Gold OA•93.43% Original Research

Aims & Scope

Harm Reduction Journal is an Open Access, peer-reviewed, online journal whose focus is on the prevalent patterns of psychoactive drug use, the public policies meant to control them, and the search for effective methods of reducing the adverse medical, public health, and social consequences associated with both drugs and drug policies. We define "harm reduction" as "policies and programs which aim to reduce the health, social, and economic costs of legal and illegal psychoactive drug use without necessarily reducing drug consumption". We are especially interested in studies of the evolving patterns of drug use around the world, their implications for the spread of HIV/AIDS and other blood-borne pathogens.

Topics Covered (Recognized by AI)
Medicine98.5%Pathology85.4%Biology85.1%Psychology84.9%Nursing83.4%Public health77.4%Psychiatry67.6%Sociology62.8%Family medicine61.5%Political science60.1%Law58.3%Immunology55.8%Virology55.7%Health psychology55.5%Human immunodeficiency virus (HIV)52.7%Environmental health49%Internal medicine46.7%Harm reduction43%Demography35%Economics34.3%Pharmacology31.2%Mathematics28.5%Social psychology27.2%Population25.1%Computer science24.8%Chemistry24.8%Statistics24.7%Economic growth22.2%Biochemistry22%Drug21.9%Anthropology21.8%Genetics21.4%Social science21.1%Geography21%Business20.4%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSSCI2026

SUBSTANCE ABUSE

Q1
Rank5/61
IndexSSCI
JCISSCI2026

SUBSTANCE ABUSE

Q1
Rank4/61
IndexSSCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.2
Articles / Year143
Total Citations32
2025
IF4
Articles / Year222
Total Citations623
2024
IF4
Articles / Year230
Total Citations1,712
2023
IF4.4
Articles / Year180
Total Citations2,506
2022
IF4.756
Articles / Year145
Total Citations2,834

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,393Scopus Q1SCImago Profile
Scopus Coverage:2004-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.513

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.80

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,539 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,202
3-Year Documents530
Citable Documents511

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)8

Citations in government and international policy documents

Female Author Rate59.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
Psychiatry and Mental HealthQ1
Public Health, Environmental and Occupational HealthQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 12.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
1区SUBSTANCE ABUSE
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Harm Reduction Journal (ISSN: 1477-7517) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 4.20, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.513 (Q1), an H-index of 76.

The journal enforces rigorous peer evaluation with an annual output of approximately 126 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,539 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
Periodic
Indexing & Databases
SSCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 6302b8da-bc30-444c-9427-bff3d671932f
Database Updated: 2026-10-01